BMJ Group: Rise in Private Testosterone Prescribing Risks Overtreatment and More Strain on the NHS
October 16, 2026
October 16, 2026
LONDON, England, Oct. 16 (TNSjou) -- BMJ Group issued the following news release about The BMJ:
* * *
Rise in private testosterone prescribing risks overtreatment and more strain on the NHS
Experts call for national data on private prescriptions to close the evidence gap
-
The rapid expansion of private testosterone prescribing risks extending treatment beyond men with clearly defined need to people with non-specific symptoms and b . . .
* * *
Rise in private testosterone prescribing risks overtreatment and more strain on the NHS
Experts call for national data on private prescriptions to close the evidence gap
-
The rapid expansion of private testosterone prescribing risks extending treatment beyond men with clearly defined need to people with non-specific symptoms and b . . .